Skip to Main Content

After years of complaints, the Federal Trade Commission has sent letters to lawyers to warn that some ads seeking clients to file lawsuits may misrepresent the risks associated with certain medicines, and possibly worry consumers that a product recall may be under way.

In a statement, the agency indicated letters were sent to seven lawyers, as well as people who generate leads for potential lawsuits, saying such ads may be considered deceptive or unfair under federal law. Some of the ads may make deceptive or unsubstantiated claims about the risks of taking blood thinners and drugs for diabetes, acid reflux, and high blood pressure, among other illnesses, the FTC explained.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!